Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

Stress, nutritional issues, and chronic diseases can cause hair loss, and nail changes may signal internal diseases; treatment focuses on the underlying cause.

Tacrolimus is an effective treatment for several skin conditions with fewer side effects than cyclosporine.

High doses of fluconazole can cause reversible hair loss.

Certain foods and supplements can help treat skin diseases alongside medication.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

Scientists found a new gene in a bacterium that can modify an immunosuppressant drug, potentially helping to treat hair loss.

Terbinafine can cause hair loss.

A woman with low thyroid function did not lose her hair during chemotherapy, possibly because her hair follicles were less affected by the treatment.

Scalp tourniquets did not significantly prevent hair loss from chemotherapy.

The conclusion is that effective cancer treatment often requires a combination of therapies, but must be carefully managed due to serious side effects and the risk of immunosuppression.

Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.

Use trichoscopy to diagnose hair loss; treat with minoxidil, finasteride, or dutasteride; consider platelet-rich plasma and spironolactone.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

A woman's hair loss during Hepatitis C treatment with PEG-INF-a-2a and Ribavirin was reversible after stopping the medication.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

The Cross-section Trichometer is a promising tool for measuring hair characteristics without cutting the hair and may have various clinical uses.

Get head MRI for babies with achondroplasia early, use free immunoglobulin light chains to detect certain neurodevelopmental disorders, and video calls work for speech therapy in patients with facial anomalies.

Chemotherapy can cause skin side effects that affect patients' lives, but they can be managed to avoid interrupting cancer treatment.

Marine-derived ingredients show potential for hair health but need more human trials to confirm effectiveness.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

Docetaxel, a chemotherapy drug, was reported to cause psoriasis in a patient for the first time.

No FDA-approved treatments for chemotherapy-induced hair loss existed in 2006; more research was needed.

Hair loss in three Southeast Asian women with kidney failure may be linked to their anemia treatment with erythropoietin.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

Dorper sheep's wool shedding is linked to specific genes and pathways, which may help understand human hair growth.

A compound from Calophyllum inophyllum L. leaf may help treat non-small cell lung cancer.

Ayurvedic herbs may reduce side effects and improve effectiveness of cancer treatments.

Histone modification is key in treating chronic inflammatory skin diseases.